In conclusion, this study shows that fucoxanthin was more effective in MDA-MB-231 TNBC, where it can target VEGF-A and VEGF-C, inhibit cell proliferation, cell migration, and induce cell cycle arrest and apoptosis, which are cellular processes involved in breast cancer development and progression. Here, VEGFA is linked to breast cancer.